Etoricoxib as a treatment of choice for patients with SLCO2A1 mutation exhibiting autosomal recessive primary hypertrophic osteoarthropathy: A case report
- Areej Albawa'neh
- , Mariam Ghareeb Al Mansoori
- , Sehriban Diab
- , Fatma Al Jasmi
- , Nadia Akawi
Research output: Contribution to journal › Article › peer-review
5
Link opens in a new tab
Citations
(Scopus)